Children, adolescents, and adults aged 2 years or older with a diagnosis of atopic dermatitis which has persisted for more than 6 months are needed for this clinical research trial. Eligible participants must have mild to moderate disease and no active or acute skin infections.
Participants will receive investigational topical treatment (active study drug) or placebo (inactive substance), via a cream. Study treatment and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will be provided.
Study participation will last about 10 weeks and involve about 7 visits to the study centre.
The following information is from ClinicalTrials.gov
Last Update Posted: February 01, 2023
Condition or Disease:
Atopic Dermatitis (Eczema)
Ages Eligible for Study:
2 Years and Older
Sexes Eligible for Study:
Male and Female
Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.